首页 > 市场调查报告书 > 製药

妇科治疗

市场调查报告书

商品编码

1356798

子宫内膜异位症市场报告：2030 年趋势、预测与竞争分析

Endometriosis Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2023年09月01日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

子宫内膜异位症趋势与预测

预计到 2030 年，全球子宫内膜异位症市场将达到 31 亿美元，2024 年至 2030 年年复合成长率为 13.1%。这个市场的主要促进因素是子宫内膜异位症研究资金的增加、感染疾病爆发和流行病的激增以及人们对子宫内膜异位症的认识不断提高。仅此而已。全球子宫内膜异位症市场的未来前景广阔，医院、居家医疗和专科中心市场充满机会。

子宫内膜异位症市场洞察

Lucintel预计，在预测期内，由于表浅腹膜病变的患病不断上升，以及旨在提高人们对子宫内膜异位症认识的计划以及政府对子宫内膜异位症研究的资助增加，我们预测表浅腹膜病变将呈现最高成长。

由于医院药局数量不断增加，且病患对医院优质服务和设施的偏好不断增加，医院可能仍是最大的细分市场。

由于子宫内膜异位症患者患病不断上升以及该地区市场参与企业不断增加的战略配合措施，预计亚太地区在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

Q.1. 细分市场中最有前途和高成长的机会是什么？
Q.2. 未来哪个细分市场成长较快？为什么？
Q.3.您认为哪些地区未来会出现更快的成长？为什么？
Q.4. 影响市场动态的主要要素有哪些？市场的主要挑战和商业风险是什么？
Q.5. 这个市场的商业风险和竞争威胁是什么？
Q.6.这个市场有哪些新趋势？为什么？
Q.7.市场客户需求有何改变？
Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

宏观经济趋势（2018-2023）与预测（2024-2030）
全球子宫内膜异位症市场趋势（2018-2023）与预测（2024-2030）
全球子宫内膜异位症市场（按类型）
- 表浅腹膜病变
- 子宫内膜异位症
- 其他的
按配销通路分類的全球子宫内膜异位症市场
- 医院药房
- 网路药房
- 零售药房
按治疗分類的全球子宫内膜异位症市场
- 口服避孕药
- 促性腺激素释放激素 (GnRH) 药物
- 其他的
以最终用途行业分類的全球子宫内膜异位症市场
- 医院
- 居家护理
- 专业中心
- 其他的

第4章2018-2030年分地区市场趋势及预测分析

全球子宫内膜异位症市场（按地区）
北美子宫内膜异位症市场
欧洲子宫内膜异位症市场
亚太子宫内膜异位症市场
其他区域子宫内膜异位症市场

第5章竞争分析

产品系列分析
营运整合
波特五力分析

第6章成长机会与策略分析

成长机会分析
- 按类型分類的全球子宫内膜异位症市场成长机会
- 全球子宫内膜异位症市场成长机会（按配销通路）
- 全球子宫内膜异位症市场的治疗方法成长机会
- 最终用途产业的全球子宫内膜异位症市场成长机会
- 全球子宫内膜异位症市场成长机会（按地区）
全球子宫内膜异位症市场的新兴趋势
战略分析
- 新产品开发
- 扩大全球子宫内膜异位症市场的产能
- 全球子宫内膜异位症市场的合併、收购及合资企业
- 认证和许可

第7章主要企业概况

Consilient Health
Sun Pharmaceutical
Sanofi
AstraZeneca
Serum Institute of India
Pfizer
Teva Pharmaceutical Industries
GlaxoSmithKline
Merck
Abbott Laboratories

简介目录

Endometriosis Trends and Forecast

The future of the global endometriosis market looks promising with opportunities in the hospital, homecare, and speciality center markets. The global endometriosis market is expected to reach an estimated $3.1 billion by 2030 with a CAGR of 13.1% from 2024 to 2030. The major drivers for this market are increasing funding for endometriosis research, surge in infectious disease outbreaks and pandemics is observed, and growing awareness towards endometriosis.

A more than 150-page report is developed to help in your business decisions.

Endometriosis by Segment

The study includes a forecast for the global endometriosis by type, distribution channel, treatment, end use industry, and region.

Endometriosis Market by Type [Shipment Analysis by Value from 2018 to 2030]:

Superficial Peritoneal Lesion
Endometriomas
Others

Endometriosis Market by Distribution channel [Shipment Analysis by Value from 2018 to 2030]:

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy

Endometriosis Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

Oral Contraceptives
Gonadotropin-Releasing Hormone (GnRH) Medicines
Others

Endometriosis Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

Hospitals
Homecare
Speciality Centers
Others

Endometriosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Endometriosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies endometriosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the endometriosis companies profiled in this report include-

Consilient Health
Sun Pharmaceutical
Sanofi
Astrazeneca
Serum Institute Of India
Pfizer
Teva Pharmaceutical Industries
Glaxosmithkline
Merck
Abbott Laboratories

Endometriosis Market Insights

Lucintel forecasts that superficial peritoneal lesion is expected to witness highest growth over the forecast period due to the rising prevalence of superficial peritoneal lesions, coupled with programs aimed at boosting endometriosis awareness and increased government funding for endometriosis research.

Hospitals will remain the largest segment due to the increase in the number of hospital pharmacies and growing patient preference for hospitals due to their high-quality services and facilites.

APAC is expected to witness highest growth over the forecast period due to the increasing prevalence of endometriosis cases and rising number of strategic intiatives by market players in the region.

Features of the Global Endometriosis Market

Market Size Estimates: Endometriosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Endometriosis market by various segments, such as by type, distribution channel, treatment, end use industry and region in terms of($B).

Regional Analysis: Endometriosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, distribution channels, treatments, end use industries, and region.s for the endometriosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the endometriosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the endometriosis market size?

Answer: The global endometriosis market is expected to reach an estimated $3.1 billion by 2030.

Q.2. What is the growth forecast for endometriosis market?

Answer: The global endometriosis market is expected to grow with a CAGR of 13.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the endometriosis market?

Answer: The major drivers for this market are increasing funding for endometriosis research, surge in infectious disease outbreaks and pandemics is observed, and growing awareness towards endometriosis.

Q.4. What are the major segments for endometriosis market?

Answer: The future of the endometriosis market looks promising with opportunities in the hospital, homecare, and speciality center markets.

Q.5. Who are the key Endometriosis Market companies?

Answer: Some of the key endometriosis companies are as follows:

Consilient Health
Sun Pharmaceutical
Sanofi
AstraZeneca
Serum Institute of India
Pfizer
Teva Pharmaceutical Industries
GlaxoSmithKline
Merck
Abbott Laboratories

Q.6. Which endometriosis market segment will be the largest in future?

Answer: Lucintel forecasts that superficial peritoneal lesion is expected to witness highest growth over the forecast period due to the rising prevalence of superficial peritoneal lesions, coupled with programs aimed at boosting endometriosis awareness and increased government funding for endometriosis research.

Q.7. In endometriosis market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to the increasing prevalence of endometriosis cases and rising number of strategic intiatives by market players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the endometriosis market by type (superficial peritoneal lesion, endometriomas, and others), distribution channel (hospital pharmacy, online pharmacy, and retail pharmacy), treatment (oral contraceptives, gonadotropin-releasing hormone (GnRH) medicines, and others), end use industry (hospitals, homecare, speciality centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Endometriosis Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Endometriosis Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Endometriosis Market by Type
- 3.3.1: Superficial Peritoneal Lesion
- 3.3.2: Endometriomas
- 3.3.3: Others
3.4: Global Endometriosis Market by Distribution channel
- 3.4.1: Hospital Pharmacy
- 3.4.2: Online Pharmacy
- 3.4.3: Retail Pharmacy
3.5: Global Endometriosis Market by Treatment
- 3.5.1: Oral Contraceptives
- 3.5.2: Gonadotropin-Releasing Hormone (GnRH) Medicines
- 3.5.3: Others
3.6: Global Endometriosis Market by End Use Industry
- 3.6.1: Hospitals
- 3.6.2: Homecare
- 3.6.3: Speciality Centers
- 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Endometriosis Market by Region
4.2: North American Endometriosis Market
- 4.2.2: North American Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others
4.3: European Endometriosis Market
- 4.3.1: European Endometriosis Market by Type: Superficial Peritoneal Lesion, Endometriomas, and Others
- 4.3.2: European Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others
4.4: APAC Endometriosis Market
- 4.4.1: APAC Endometriosis Market by Type: Superficial Peritoneal Lesion, Endometriomas, and Others
- 4.4.2: APAC Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others
4.5: ROW Endometriosis Market
- 4.5.1: ROW Endometriosis Market by Type: Superficial Peritoneal Lesion, Endometriomas, and Others
- 4.5.2: ROW Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Endometriosis Market by Type
- 6.1.2: Growth Opportunities for the Global Endometriosis Market by Distribution channel
- 6.1.3: Growth Opportunities for the Global Endometriosis Market by Treatment
- 6.1.4: Growth Opportunities for the Global Endometriosis Market by End Use Industry
- 6.1.5: Growth Opportunities for the Global Endometriosis Market by Region
6.2: Emerging Trends in the Global Endometriosis Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Endometriosis Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Endometriosis Market
- 6.3.4: Certification and Licensing